Pearson syndrome in the neonatal period: Two case reports and review of the literature

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 12, 2009, Pages 947-951

  Manea, Elena Maria ^a   Leverger, Guy ^a   Bellmann, Francoise ^a   Stanescu, Popp Alina ^c   Mircea, Adam ^a   Lèbre, Anne Sophie ^b   Rötig, Agnes ^b   Munnich, Arnold ^b  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Alfred Rusescu Institute   (France)

Author keywords

Neonatal; Pearson syndrome

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; BONE MARROW CELL; CASE REPORT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA SEQUENCE; HUMAN; MALE; NEWBORN; NEWBORN DISEASE; ONSET AGE; OXIDATIVE PHOSPHORYLATION; PEARSON SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; AGRANULOCYTOSIS; APLASTIC ANEMIA; GENE DELETION; GENETICS; MACROCYTIC ANEMIA; PRESCHOOL CHILD; REVIEW; SYNDROME; THROMBOCYTOPENIA;

AGRANULOCYTOSIS; ANEMIA, APLASTIC; ANEMIA, MACROCYTIC; CHILD, PRESCHOOL; DNA, MITOCHONDRIAL; GENE DELETION; HUMANS; INFANT, NEWBORN; MALE; MITOCHONDRIAL DISEASES; OXIDATIVE PHOSPHORYLATION; SYNDROME; THROMBOCYTOPENIA;

EID: 73949119072     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181bbc4ef     Document Type: Article

References (54)

1. Pearson HA, Lobel JS, Kocoshis SA, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr. 1979;95:976-984.
2. Faraci M, Cuzzubbo D, Micalizzi C, et al. Allogeneic bone marrow transplantation for Pearson's syndrome. Bone Marrow Transplant. 2007;39:563-565.
3. Rötig A, Colonna M, Bonnefort JP, et al. Mitochondrial DNA deletion in Pearson's marrow and pancreas syndrome. Lancet. 1989;1:902-903.
4. Rötig A, Bourgeron T, Chretien D, et al. Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet. 1995;4:1327-1330.
5. McShane MA, Hammans SR, Sweeney M, et al. Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet. 1991;48:39-42.
6. Rötig A, Cormier V, Blanche S, et al. Pearson's marrow-pancreas syndrome: a multisystem mitochondrial disorder in infancy. J Clin Invest. 1990;86:1601-1608.
7. Van den Ouweland JMW, De Klerk JBC, Van de Corput MP, et al. Characterization of a novel mitochondrial DNA deletion in a patient with a variant of the Pearson marrow-pancreas syndrome. Eur J Hum Genet. 2000;8:195-203.
8. Santorelli FM, Barmada MA, Pons R, et al. Leigh-type neuropathology in Pearson syndrome associated with impaired ATP production and a novel mtDNA deletion. Neurology. 1996;47:1320-1323.
9. Cormier V, Rötig A, Quartino AR, et al. Widespread multitissue deletions of the mitochondrial genome in the Pearson marrow-pancreas syndrome. J Pediatr. 1990;117: 599-602.
10. Baerlocher KE, Feldges A, Weissert M, et al. Mitochondrial DNA deletion in an 8-year-old boy with Pearson syndrome. J Inherit Metab Dis. 1992;15:327-330.
11. Gürgey A, Rötig A, Gümrük F, et al. Pearson's marrow-pancreas syndrome in 2 Turkish children. Acta Haematol. 1992;87:206-209.
12. Superti-Furga A, Schoenle E, Tuchschmid P, et al. Pearson bone marrow-pancreas syndrome with insulin-dependent diabetes, progressive renal tubulopathy, organic aciduria and elevated fetal haemoglobin caused by deletion and duplication of mitochondrial DNA. Eur J Pediatr. 1993;152:44-50.
13. Bernes SM, Bacino C, Prezant TR, et al. Identical mitochondrial DNA deletion in mother with progressive external ophthalmoplegia and son with Pearson marrow-pancreas syndrome. J Pediatr. 1993;123:598-602.
14. Ribes A, Riudor E, Valcá rel R, et al. Pearson syndrome: altered tricarboxylic acid and urea-cycle metabolites, adrenal insufficiency and corneal opacities. J Inherit Metab Dis. 1993; 16:537-540.
15. Blatt J, Katerji A, Barmada M, et al. Pancytopenia and vacuolation of marrow precursors associated with necrotizing encephalopathy. Br J Haematol. 1994;86:207-209.
16. Bader-Meunier B, Rötig A, Mielot F, et al. Refractory anaemia and mitochondrial cytopathy in childhood. Br J Haematol. 1994;87:381-385.
17. Kapsa R, Thompson GN, Thorburn DR, et al. A novel mtDNA deletion in an infant with Pearson syndrome. J Inherit Metab Dis. 1994;17:521-526.
18. Niaudet P, Heidet L, Munnich A, et al. Deletion of the mitochondrial DNA in a case of de Toni-Debré-Fanconi syndrome and Pearson syndrome. Pediatr Nephrol. 1994;8:164-168.
19. Smith OP, Hann IM, Woodward CE, et al. Pearson's marrow/pancreas syndrome: haematological features associated with deletion and duplication of mitochondrial DNA. Br J Haematol. 1995;90:469-472.
20. Gürgey A, Özalp i, Rötig A, et al. A case of Pearson syndrome associated with multiple renal cysts. Pediatr Nephrol. 1996;10: 637-638.
21. Kleinle S, Wiesmann U, Superti-Furga A, et al. Detection and characterization of mitochondrial DNA rearrangements in Pearson and Kearns-Sayre syndromes by long PCR. Hum Genet. 1997;100:643-650.
22. Muraki K, Nishimura S, Goto Y, et al. The association between haematological manifestation and mtDNA deletions in Pearson syndrome. J Inherit Metab Dis. 1997;20:697-703.
23. Muraki K, Goto Y, Nishino I, et al. Severe lactic acidosis and neonatal death in Pearson syndrome. J Inherit Metab Dis. 1997;20:43-48.
24. Muraki K, Sakura N, Ueda H, et al. Clinical implications of duplicated mtDNA in Pearson syndrome. Am J Med Genet. 2001;98:205-209.
25. Seneca S, De Meirleir L, De Schepper J, et al. Pearson marrow pancreas syndrome: a molecular study and clinical management. Clin Genet. 1997;51:338-342.
26. Cursiefen C, Küchle M, Scheurlen W, et al. Bilateral zonular cataract associated with the mitochondrial cytopathy of Pearson syndrome. Am J Ophthalmol. 1998;125:260-261.
27. Tó th T, Bó kay J, Szonyi L, et al. Detection of mtDNA deletion in Pearson syndrome by two independent PCR assays from Guthrie card. Clin Genet. 1998;53:210-213.
28. Warris A, Verweij PE, Barton R, et al. Invasive aspergillosis in two patients with Pearson syndrome. Pediatr Infect Dis J. 1999;18:739-741.
29. Lacbawan F, Tifft CJ, Luban NLC, et al. Clinical heterogeneity in mitochondrial DNA deletion disorders: a diagnostic challenge of Pearson syndrome. Am J Med Genet. 2000;95: 266-268.
30. Yanagibara I, Inui K, Yanagibara K, et al. Fluorescence in situ hybridization analysis of peripheral blood cells in Pearson marrow-pancreas syndrome. J Pediatr. 2001;139:452-455.
31. Shanske S, Tang Y, Hirano M, et al. Identical mitochondrial DNA deletion in a woman with ocular myopathy and in her son with Pearson syndrome. Am J Hum Genet. 2002;71:679-683.
32. Krauch G, Wilichowski E, Schmidt KG, et al. Pearson marrow-pancreas syndrome with worsening cardiac function caused by pleiotropic rearrangement of mitochondrial DNA. Am J Med Genet. 2002;110:57-61.
33. Knerr I, Metzler M, Niemeyer CM, et al. Hematologic features and clinical course of an infant with Pearson syndrome caused by a novel deletion of mitochondrial DNA. J Pediatr Hematol Oncol. 2003;25:948-951.
34. Jacobs LJAM, Jongbloed RJE, Wijburg FA, et al. Pearson syndrome and the role of deletion dimers and duplications in the mtDNA. J Inherit Metab Dis. 2004;27:47-55.
35. Morikawa Y, Matsuura N, Kakudo K, et al. Pearson's marrow/pancreas syndrome: a histological and genetic study. Virchows Arch A Pathol Anat Histopathol. 1993;423:227-231.
36. De Vries DD, Ruitenbeek W, van Oost BA. Detection of extremely low levels of wild-type mitochondrial DNA in the liver of a patient with Pearson syndrome by a sensitive PCR assay. J Inherit Metab Dis. 1992;15:307-310.
37. Gürakan B, Ozbek N, Varan B, et al. Fatal acidosis in a neonate with Pearson syndrome. Turk J Pediatr. 1999;41: 361-364.
38. Sano T, Ban K, Ichiki T, et al. Molecular and genetic analyses of two patients with Pearson's marrow-pancreas syndrome. Pediatr Res. 1993;34:105-110.
39. Lee HF, Lee HJ, Chi CS, et al. The neurological evolution of Pearson syndrome: case report and literature review. Eur J Pediatric Neurol. 2007;11:208-214.
40. Lichter-Konecki U, Trefz FK, Rötig A, et al. 3-Methylglutaconic aciduria in a patient with Pearson syndrome. Eur J Pediatr. 1993;152:378.
41. Li CH, Lam CW, Lee CWA, et al. Pearson's syndrome: a rare cause of non-immune hydrops fetalis. Chin Med J. 2003;116: 1952-1954.
42. Rahman S, Leonard JV. Early onset of complete heart block in Pearson syndrome. J Inherit Metab Dis. 2000;23:753-754.
43. Lohi O, Kuusela AL, Arola M. A novel deletion in a Pearson syndrome infant with hypospadias and cleft lip and palate. J Inherit Metab Dis. 2005;28:1165-1166.
44. Demeocq F, Storme B, Schaison G, et al. Anémie réfractaire sidéroblastique avec vacuolisation des précurseurs médullaires et deficit de la fonction exocrine du pancré as. Etude d'une nouvelle observation. Arch Fr Pediatr. 1983;40:631-635.
45. Stoddard RA, McCurnin DC, Shultenover SJ, et al. Syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction presenting in the neonate. J Pediatr. 1981;99:259-261.
46. Favareto F, Caprino D, Micalizzi C, et al. New clinical aspects of Pearson's syndrome: report of three cases. Haematologica. 1989;74:591-594.
47. Van de Corput MP, Van den Ouweland JM, Dirks RW, et al. Detection of mitochondrial DNA deletions in human skin fibroblasts of patients with Pearson's syndrome by two-color fluorescence in situ hybridization. J Histochem Cytochem. 1997;45:55-61.
48. Sansone G, Masera G, Terzoli S, et al. Congenital refractory anaemia with vacuolization of bone marrow precursors, sideroblastosis and growth failure in a girl with normal endocrine pancreatic function. Haematologica. 1989;74:587-590.
49. Jakobs C, Danse P, Veerman AJP. Organic aciduria in Pearson syndrome. Eur J Pediatr. 1991;150:684.
50. Morris AAM, Lamont PJ, Clayton PT. Pearson's syndrome without marrow involvement. Arch Dis Child. 1997;77: 56-57.
51. De Vries DD, Buzing CJM, Ruitenbeek W, et al. Myopathology and a mitochondrial deletion in the Pearson marrow and pancreas syndrome. Neuromusc Disord. 1992;2:185-195.
52. Gibson KM, Bennett J, Mize CE, et al. 3-Metylglutaconic aciduria associated with Pearson syndrome and respiratory chain defects. J Pediatr. 1992;121:940-942.
53. Rötig A, Cormier V, Koll F, et al. Site specific deletions of the mitochondrial genome in the Pearson marrow-pancreas syndrome. Genomics. 1991;10:502-504.
54. Munakata K, Bundo M, Kato T, et al. Co-existing point mutations of mitochondrial DNA in a patient with a heart abnormality and Pearson syndrome-like symptoms. Am J Med Genet. 2005;139:162-164.